Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis
BACKGROUND: An increased lymphoma risk is well documented in systemic lupus (SLE). Less attention has been focused on women's cancers, even though SLE affects mostly females. Our objective was to estimate the risk of breast, ovarian, and endometrial cancers in SLE, relative to the general popul...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101932/ https://www.ncbi.nlm.nih.gov/pubmed/21487409 http://dx.doi.org/10.1038/bjc.2011.115 |
_version_ | 1782204324451975168 |
---|---|
author | Bernatsky, S Ramsey-Goldman, R Foulkes, W D Gordon, C Clarke, A E |
author_facet | Bernatsky, S Ramsey-Goldman, R Foulkes, W D Gordon, C Clarke, A E |
author_sort | Bernatsky, S |
collection | PubMed |
description | BACKGROUND: An increased lymphoma risk is well documented in systemic lupus (SLE). Less attention has been focused on women's cancers, even though SLE affects mostly females. Our objective was to estimate the risk of breast, ovarian, and endometrial cancers in SLE, relative to the general population. METHODS: Data were included from five recent studies of large SLE cohorts. The number of cancers observed was determined for each cancer type. The expected number of malignancies was ascertained from general population data. The parameter of interest was the standardised incidence ratio (SIR), the ratio of observed to expected malignancies. RESULTS: The five studies included 47 325 SLE patients (42 171 females) observed for 282 553 patient years. There were 376 breast cancers, 66 endometrial cancers, and 44 ovarian cancers. The total number of cancers observed was less than that expected, with SIRs of 0.76 (95% CI: 0.69, 0.85) for breast cancer, 0.71 (95% CI: 0.55, 0.91) for endometrial cancer, and 0.66 (95% CI: 0.49, 0.90) for ovarian cancer. CONCLUSIONS: Data strongly support a decreased risk of breast, ovarian, and endometrial cancers in SLE. This may be due to inherent differences in women in SLE (vs the general population) regarding endogenous oestrogen, other medications, and/or genetic make-up. |
format | Text |
id | pubmed-3101932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-31019322012-04-26 Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis Bernatsky, S Ramsey-Goldman, R Foulkes, W D Gordon, C Clarke, A E Br J Cancer Short Communication BACKGROUND: An increased lymphoma risk is well documented in systemic lupus (SLE). Less attention has been focused on women's cancers, even though SLE affects mostly females. Our objective was to estimate the risk of breast, ovarian, and endometrial cancers in SLE, relative to the general population. METHODS: Data were included from five recent studies of large SLE cohorts. The number of cancers observed was determined for each cancer type. The expected number of malignancies was ascertained from general population data. The parameter of interest was the standardised incidence ratio (SIR), the ratio of observed to expected malignancies. RESULTS: The five studies included 47 325 SLE patients (42 171 females) observed for 282 553 patient years. There were 376 breast cancers, 66 endometrial cancers, and 44 ovarian cancers. The total number of cancers observed was less than that expected, with SIRs of 0.76 (95% CI: 0.69, 0.85) for breast cancer, 0.71 (95% CI: 0.55, 0.91) for endometrial cancer, and 0.66 (95% CI: 0.49, 0.90) for ovarian cancer. CONCLUSIONS: Data strongly support a decreased risk of breast, ovarian, and endometrial cancers in SLE. This may be due to inherent differences in women in SLE (vs the general population) regarding endogenous oestrogen, other medications, and/or genetic make-up. Nature Publishing Group 2011-04-26 2011-04-12 /pmc/articles/PMC3101932/ /pubmed/21487409 http://dx.doi.org/10.1038/bjc.2011.115 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Short Communication Bernatsky, S Ramsey-Goldman, R Foulkes, W D Gordon, C Clarke, A E Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis |
title | Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis |
title_full | Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis |
title_fullStr | Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis |
title_full_unstemmed | Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis |
title_short | Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis |
title_sort | breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101932/ https://www.ncbi.nlm.nih.gov/pubmed/21487409 http://dx.doi.org/10.1038/bjc.2011.115 |
work_keys_str_mv | AT bernatskys breastovarianandendometrialmalignanciesinsystemiclupuserythematosusametaanalysis AT ramseygoldmanr breastovarianandendometrialmalignanciesinsystemiclupuserythematosusametaanalysis AT foulkeswd breastovarianandendometrialmalignanciesinsystemiclupuserythematosusametaanalysis AT gordonc breastovarianandendometrialmalignanciesinsystemiclupuserythematosusametaanalysis AT clarkeae breastovarianandendometrialmalignanciesinsystemiclupuserythematosusametaanalysis |